print-logo
Logo
  • Who we are Arrow Down
    • About us
    • Our purpose & values
    • Our team
    • News & events
  • What we do Arrow Down
    • Overview
    • Lifecycle Management
    • Government Affairs
    • Market Access
    • Medical Affairs
    • Marketing
    • Commercial Models
    • Customer & Market Insights
  • Insights Arrow Down
    • Publications
    • Project cases
    • Early Asset Strategy
    • Value Pull-Through
  • Careers Arrow Down
    • Why join us
    • Open positions
    • Career paths
    • FAQ
  • Contact
  • |
  • Search Icon
  • Search
Back to Project cases
  • linkedin_icon
  • twitter_icon
  • mail_icon
  • print_icon

Early brand building for pre-clinical asset

Early brand building for pre-clinical asset

Goal

The client wanted to understand potential future market scenarios for an asset in early phase I clinical development. There was a need to identify key areas of unmet need and decide on implications for development and target product profile (TPP) definition.

Approach

Standard of care

Analyze disease, SOC, patient journey and competitor landscape

Stakeholder needs

Map needs of all relevant stakeholders (regulators, payers, HCPs, patients)

TPP implications

Review TPP and define implications for clinical development

  • Defined 3 commercialization scenarios for the asset and implications for development
  • Reached consensus to change direction of development of the asset in order to better align with existing stakeholder needs

Learn more about this service

Lifecycle Management
Share this page
  • linkedin_icon
  • twitter_icon
  • mail_icon
  • print_icon

We use cookies to ensure we give you the best experience on our website. Detailed information on the use of cookies, and how you can disable them, is provided in our Privacy Policy. By using this site or clicking on "OK", you consent to the use of cookies.

OK
arrow_up

How can we help?

Contact us

Our offices

Careers

Footer Logo
  • Who we are
  • What we do
  • Insights
  • Careers
  • Terms of use
  • Privacy policy
  • Imprint

2022 Executive Insight. All rights reserved.